Zavain Dar serves as Executive at RECURSION PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Zavain Dar has executed 15 insider transactions totaling $181.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 2, 2026 involved receiving (via award) 3,571 shares valued at $0.
Zavain Dar currently holds 142,329 shares of RECURSION PHARMACEUTICALS, INC. (RXRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Zavain Dar has been a net seller of RXRX stock. They have purchased $0 and sold $181.3K worth of shares.
Zavain Dar's most recent insider trade was on Jan 2, 2026, when they sold 3,571 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 1, 2024 | RXRX | $0 | Award | 1,843 | $N/A | Discretionary |
| Jun 3, 2024 | RXRX | $0 | Award | 13,097 | $N/A | Discretionary |
| Apr 1, 2024 | RXRX | $0 | Award | 1,467 | $N/A | Discretionary |
| Jan 2, 2024 | RXRX | $0 | Award | 1,393 | $N/A | Discretionary |
| Dec 14, 2023 | RXRX | $181.3K | Sale | 20,141 | $9.00 | Planned |
| Oct 2, 2023 | RXRX | $0 | Award | 1,920 | $N/A | Discretionary |
| Jul 3, 2023 | RXRX | $0 | Award | 1,863 | $N/A | Discretionary |
| Jun 16, 2023 | RXRX | $0 | Award | 12,612 | $N/A | Discretionary |
| Apr 3, 2023 | RXRX | $0 | Award | 1,996 | $N/A | Discretionary |
| Apr 3, 2023 | RXRX | $0 | Award | 1,996 | $N/A | Discretionary |
| Jul 8, 2022 | RXRX | $0 | Other | 2,420 | $N/A | Discretionary |
| Jun 14, 2022 | RXRX | $0 | Award | 18,145 | $N/A | Discretionary |
| Dec 7, 2021 | RXRX | $0 | Other | 3,599 | $N/A | Discretionary |